Spend expert time on judgment, not on data entry.
In pharma and life sciences, scarce experts spend hours transcribing, reconciling and formatting documents before they can apply their judgment. We look for the operational workflows where agents can do that preparation with full traceability, while qualified people keep every safety, quality and release decision.
Six workflows where documentation outweighs decision.
These are the workflows we would examine first in a pharma, biotech, medical device or CRO operation. They run through safety databases, quality management systems, document management, LIMS, trial systems and a great deal of email.
| Workflow | Manual today | AI-native version | Stays human | Verification check |
|---|---|---|---|---|
| Adverse event case intake | Safety staff read emails, call notes and literature reports, then key each case into the safety database. | An agent extracts the case data into a draft, checks it for validity criteria and flags possible seriousness. | Seriousness, causality and expectedness assessments, and every submission. | Every field traced to its source text. A person reviews every case. Reporting clocks tracked from first receipt. |
| Deviation and CAPA documentation | Quality staff write up deviations, search for similar past events and chase owners for actions. | An agent drafts the deviation record, links similar past events and tracks CAPA actions and due dates. | Root cause, impact assessment, classification and closure. | Required fields complete before review. Overdue actions escalated. No record is closed by an agent. |
| Batch record review preparation | Reviewers page through records to find missing entries, corrections and out-of-range values. | An agent pre-checks the record and lists every gap, correction and out-of-range value with its location. | Batch disposition and release. | Out-of-range checks run against the approved specification, not model judgment. The pre-check never replaces the review. |
| Regulatory document QC | Staff check documents for consistency across sections, versions and cross-references by hand. | An agent checks cross-references, numbers and terms across a document set and lists every inconsistency. | Content, scientific judgment and sign-off. | Each finding points to the exact location. Documents are compared against the controlled version. |
| Clinical trial site document tracking | Teams chase missing site documents and reconcile trackers against the trial master file. | An agent reconciles trackers with the file, finds missing or expired documents and drafts reminders. | Any decision about site status or protocol matters. | Missing and expired items listed with dates. Reminders use approved templates. |
| Medical information requests | Requests are logged, matched to standard responses and answered by hand. | An agent logs and classifies requests and proposes the matching approved response. | Any non-standard answer, and any request that is really an adverse event report. | Only approved responses are proposed. Possible adverse events route to safety at once. |
Six numbers that show whether it worked.
The Audit measures these before anything is built. The Pilot is measured against the same numbers.
| Metric | Definition |
|---|---|
| Minutes per case or record | Expert time from receipt to a review-ready case, deviation or record. |
| Time to review-ready | Hours from receipt to a complete draft in front of the qualified reviewer. |
| Late reporting rate | Cases or reports submitted after their deadline, per 1,000. |
| Data entry correction rate | Fields corrected at review or QC, per 1,000 fields entered. |
| Overdue CAPA actions | Corrective and preventive actions past their due date. |
| Review cycle time | Days from batch completion, or document draft, to approved review. |
What can go wrong in life sciences ops, and the control for each.
Safety assessments, quality decisions and batch release stay with qualified people. Our agents prepare and check. In a validated environment, any system we build goes through your own validation and change control. We don't make regulatory claims on your behalf.
| Failure mode | Control | How we'd detect it |
|---|---|---|
| Adverse event missed | Every incoming item is screened for event signals. Doubtful items go to safety staff, never to a discard pile. | Reconciliation of all incoming items against cases created. |
| Wrong data in a safety case | Every field traced to its source text. A person reviews every case before it is committed. | Field-level correction log and QC sample. |
| Reporting deadline missed | Clock starts at first receipt, not at data entry. Cases near their deadline are escalated. | Daily deadline report. |
| Out-of-spec value overlooked | Range checks run against the approved specification in code. The agent lists findings and never removes one. | Reviewer findings compared with the pre-check list. |
| Uncontrolled change to a GxP system | Agent versions, prompts and rules are under change control with your validation approach. | Change log reviewed in each release. |
| Patient or trial data exposed | Agents see only the fields a task needs. Self-hosted, EU-hosted deployment is possible. | Access logs per agent and per task. |
Adverse event intake, from diagnostic to pilot.
Illustrative example — not a client result. The numbers below are assumptions chosen to show the method and the arithmetic. Your Audit replaces them with measured values.
| 01 | Diagnostic | Suppose a mid-sized pharma company's safety team picks "adverse event case intake" on the General track. The Snapshot might show a High leverage signal with Medium confidence, friction at the Demand/Input and Processing stages, and Level 2 (workflow augmentation) as the indicated AI depth, because every case keeps a human review. |
| 02 | Audit | Suppose the Audit measures 800 incoming reports a month at 40 minutes of intake and data entry each. That is 800 × 40 = 32,000 minutes, or about 533.3 hours a month, about 3.3 FTE at 160 hours. It also finds that about 30% of reports are serious, unclear or arrive in poor shape. |
| 03 | Pilot | Suppose the 70% routine reports arrive as a complete draft, and a safety specialist reviews every one in 15 minutes. The 30% complex reports take 45 minutes each, because they are the harder cases. The Pilot measures whether that holds. |
| Line | Assumption | Hours per month |
|---|---|---|
| Baseline | 800 reports × 40 min | 533.3 |
| Routine, after | 560 reports, all reviewed × 15 min | 140.0 |
| Complex, after | 240 reports × 45 min | 180.0 |
| After, total | 140.0 + 180.0 | 320.0 |
| Difference | 533.3 − 320.0 (about 1.3 FTE) | 213.3 |
At an assumed loaded cost of €60 an hour, 213.3 hours is about €12,800 a month. Every case still gets a full human review. The Audit would also measure time to review-ready and the late reporting rate, because a faster draft protects the deadline. It would count the new costs too: compute, safety database integration, validation effort and review time. If the numbers don't hold, the recommendation is "don't proceed".
Where our proof comes from.
We'll be plain about this. Our production proof is in AdTech, not life sciences. We have not yet run these pharma or life sciences workflows for a client.
The architecture is the same one that runs in AdTech production: typed intake, deterministic checks before anything commits, bounded retries, then a person, with a record of every step. Our governance working paper describes a tamper-evident audit trail and runtime controls. The case studies show the production work, and four of our AI plugins run live on reviveadservermod.com.
That is why life sciences engagements start with the free diagnostic and the Audit. The Audit measures your own baseline and records your quality and validation constraints before anything is designed.
Questions life sciences operations leaders ask first.
Will an agent make safety or quality decisions?
No. Seriousness and causality assessments, deviation classification, CAPA closure and batch release stay with qualified people. Agents prepare drafts and check them against your rules and specifications.
How does this work in a validated GxP environment?
Anything we build follows your validation and change control approach. Rules, prompts and agent versions are controlled like any other configuration. The Audit records these constraints first, so the design fits them.
Does this replace our safety database or QMS?
No. Those remain the systems of record. Agents work alongside them, preparing entries and checks that a person reviews before anything is committed.
Find out which life sciences workflow is worth redesigning.
Start with the free diagnostic on the Other / General Business track. Move to the Audit only if the Snapshot points to something worth measuring.
| 01 | Free AI Operational Diagnostic | 10 steps, 8–12 minutes, General track. Snapshot on screen and as a PDF. |
| 02 | Operational Leverage Audit, from $1,500 | Fixed fee, one workflow, 10–15 working days after data access. Measured baseline, verification architecture, benefit model with stated assumptions, go / no-go. |
| 03 | Pilot implementation, from $6,000 | Fixed scope. The workflow built and run in your environment, with an audit trail, measured against the Audit baseline. Typically 4–8 weeks. |